Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 325 | 521 | 0 | 0 | 0 |
| Gross Profit | 325 | 521 | N/A | N/A | N/A |
| Operating Expenses | 19,840 | 27,788 | 17,680 | 11,599 | 10,319 |
| Operating Income | -19,515 | -27,267 | -17,680 | -11,599 | -10,319 |
| Other Income | 134 | 428 | 144 | 798 | 141 |
| Pre-tax Income | -19,381 | -26,839 | -17,536 | -10,801 | -10,178 |
| Income Tax | 48 | 14 | -7 | 2,584 | -185 |
| Net Income Continuous | -19,429 | -26,853 | -17,529 | -13,385 | -9,993 |
| Net Income | $-19,429 | $-26,853 | $-17,529 | $-13,385 | $-9,993 |
| EPS Basic Total Ops | -0.45 | -0.63 | -0.42 | 21.54 | -0.24 |
| EPS Basic Continuous Ops | -0.45 | -0.63 | -0.42 | 20.89 | -0.24 |
| EPS Diluted Total Ops | -0.45 | -0.63 | -0.42 | 21.54 | -0.24 |
| EPS Diluted Continuous Ops | -0.45 | -0.63 | -0.42 | 20.89 | -0.24 |
| EBITDA(a) | $-19,330 | $-27,113 | $-17,569 | $-11,490 | $-10,216 |